BEZ235 25 mg | ≥98% LKT Laboratories, Inc. PI3K and mTOR inhibitor. More Information Supplier Page × BEZ235
BEZ235 10 mg | ≥98% LKT Laboratories, Inc. PI3K and mTOR inhibitor. More Information Supplier Page × BEZ235
CAY10505 25 mg | ≥98% LKT Laboratories, Inc. p110γ PI3K inhibitor. More Information Supplier Page × CAY10505
CAY10505 10 mg | ≥98% LKT Laboratories, Inc. p110γ PI3K inhibitor. More Information Supplier Page × CAY10505
CAY10505 5 mg | ≥98% LKT Laboratories, Inc. p110γ PI3K inhibitor. More Information Supplier Page × CAY10505
NVP-BGT226 10 mg | ≥98% LKT Laboratories, Inc. PI3K and mTOR inhibitor. More Information Supplier Page × NVP-BGT226
PP-121 1 mg | ≥98% LKT Laboratories, Inc. p110α PI3K, DNA-PK, mTOR, Abl, Hck, Src, VEGFR2, PDGFR inhibitor. More Information Supplier Page × PP-121
PX-866 10 mg | ≥98% LKT Laboratories, Inc. Wortmannin analog; PI3K inhibitor. More Information Supplier Page × PX-866
PX-866 5 mg | ≥98% LKT Laboratories, Inc. Wortmannin analog; PI3K inhibitor. More Information Supplier Page × PX-866
PX-866 1 mg | ≥98% LKT Laboratories, Inc. Wortmannin analog; PI3K inhibitor. More Information Supplier Page × PX-866
